On Monday, November 16, 2020, the Company, Inovio Pharmaceuticals, Inc., INO stock construct a change of 14.53 percent (Gain) in a total of its share price and having its trading value $12.85, which belongs to Healthcare sector and Biotechnology industry. The company?s Market capitalization was $2.20B with the total Outstanding Shares of 169.41M.
P/S, P/E, P/B & P/C values of (NASDAQ: INO):
Inovio Pharmaceuticals, Inc. institutional ownership is standing at 34.5 percent, while insider ownership is 0.8 percent. As of now, INO has a P/S, P/E and, P/B values of 1049.54, 0, and 6.56 respectively. Its P/Cash is valued at 6.54.
The stock SMA50 is now at 6.45 percent. In looking, the SMA 200 we see that the stock has seen a 0.5 percent. The Company?s net profit margin for the 12 months at 0 percent. Comparatively, the gazes have a Gross margin of 0 percent.
Profitability ratios:
Looking into the profitability ratios of INO stock, an investor will find its ROE, ROA, ROI standing at -103 percent, -52.7 percent and, -137.9 percent, respectively.
Beta Factor:
A beta factor is used to measure the volatility of the stock. The stock remaining at 14.13 percent volatile for the week and 8.91 percent for the month.
Gross / Operating Margins of INO:
It calculates how much out of every dollar of sales a company actually keeps in earnings. Gross Margin is seen at 0 percent & Operating Margin seen at 0 percent.
Target Price:
Target Price informs the investors, aÿstockÿsurvey at which a trader is willing to buy or sell aÿstock.ÿAt which a trader projects that a buyer will buy a product. The company Inovio Pharmaceuticals, Inc. recorded it at $13.29.
Historical Performance In The News:
Taking a look at the performance of Inovio Pharmaceuticals, Inc. stock, an investor will come to know that the weekly performance for this stock is valuing at 51.18 percent, resulting in a performance for the month at 8.44 percent.
Therefore, the stated figure displays a quarterly performance of -9.41 percent, bringing six-month performance to -11.74 percent and year to date performance of 289.39 percent. As of now, Inovio Pharmaceuticals, Inc. has a P/S, P/E and, P/B values of 1049.54, 0, and 6.56 respectively. Its P/Cash is valued at 6.54.
Earnings per Share Details of Inovio Pharmaceuticals, Inc.:
The EPS of INO is strolling at -1.35, measuring its EPS growth this year at -15.4 percent. As a result, the company has an EPS growth of 55.2 percent for the approaching year.
